tradingkey.logo


Avalon Globocare Corp

ALBT

詳现チャヌトを衚瀺

2.690USD

-0.030-1.10%
終倀 09/19, 16:00ET15分遅れの株䟡
6.32M時䟡総額
損倱額盎近12ヶ月PER


Avalon Globocare Corp

2.690

-0.030-1.10%
Intraday
1m
30m
1h
D
W
M
D

本日

-1.10%

5日間

-3.93%

1ヶ月

+32.51%

6ヶ月

-58.87%

幎初来

-17.48%

1幎間

-13.82%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

通貚: USD 曎新時刻: 2025-09-19

䞻芁むンサむト

同瀟の財務状況は比范的匱いです。同瀟の株䟡は適正䟡栌ず評䟡されおいたす。たた、機関投資家による認知床は非垞に高いです。同瀟の株䟡は非垞に䜎調で、ファンダメンタルズずテクニカルも同様に䜎氎準です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

株匏スコア

関連情報

業界内順䜍
150 / 207
党䜓ランキング
490 / 4720
業皮
医療機噚 & 備品

支持線ず抵抗線

デヌタなし

レヌダヌチャヌト

珟圚
前回倀

アナリスト目暙株䟡

0 人のアナリスト予想に基づく
--
珟圚の評䟡
--
目暙株䟡
--
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

䌁業ハむラむト

匷みリスク
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
成長䞭
同瀟は成長フェヌズにあり、最新の幎間収益はUSD 1.33Mに達しおいたす。
割高
同瀟の最新のPEは-0.22で、過去3幎間の氎準ず比范しお高倀圏にありたす。
機関投資家の買い増し
最新の機関投資家の保有株数は494.33K株で、前四半期比で14.69%増加しおいたす。
バンガヌドが保有
スタヌ投資家バンガヌドは本銘柄を1.58K株保有しおいたす。
垂堎掻動が䜎調
同瀟ぞの投資家の関心は䜎䞋しおおり、20日間の売買回転率は-0.97です。

ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

デヌタなし

総売䞊高

デヌタなし

䌁業名

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
䌁業コヌドALBT
䌁業名Avalon Globocare Corp
最高経営責任者「CEO」Dr. David Jin, M.D., Ph.D.
りェブサむトhttps://www.avalon-globocare.com/
KeyAI
î™